Standard Biotools reported $19.28M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Agilent USD 339M 34M Mar/2026
Becton, Dickinson and Co. USD -311M 693M Mar/2026
Bio-Rad Laboratories USD 720M 1.06B Dec/2025
Bruker USD 3.5M 22.5M Mar/2026
Danaher USD 1.03B 168M Mar/2026
Illumina USD 134M 200M Mar/2026
Myriad Genetics USD -7.9M 19.5M Dec/2025
Nikon Corporation JPY 1.13B 93.7B Mar/2026
Pacific Biosciences Of California USD -40.37M 2.37M Dec/2025
Revvity USD 40.72M 57.65M Mar/2026
Roche Holding CHF 5.47B 1.76B Dec/2025
Sony JPY 82.87B 1.09T Mar/2026
Standard Biotools USD 19.28M 53.97M Dec/2025
Thermo Fisher Scientific USD 1.65B 313M Mar/2026
Waters USD -72M 297.21M Mar/2026